First Citizens BancShares Stock (NASDAQ: FCNCO)

First Citizens BancShares (NASDAQ:FCNCO) Stock, Quote.Headers.trade-ideas

First Citizens BancShares

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Markets

ETFs

FCNCO

MTUM

QQQM

The markets saw some green Monday after First Citizens Bank &amp; Trust Co (NASDAQ: FCNCO) agreed to buy most of Silicon Valley Bank.

The S&amp;P 500 was up 0.29%, the Dow Jones Industrial Average gained 0.7%, while the NASDAQ Composite dropped 0.49% on the day.

Mid-Cap Monday: ETF Fund Flows

silicon valley bank shutter6

Fintech news covering the emerging Financial Technology services sector

Fintech

Exclusives

Tech

General

FCNCA

The collapse of Silicon Valley Bank has sounded an alarm for the entire banking sector. 

How A $700M Tech VC Firm Was Saved From SVB Collapse, And Why Its CEO Still Banks There

First Citizens BancShares, Inc. - 5.625% Non-Cumulative Perpetual Preferred Stock, Series C

First Citizens BancShares Inc

WIIM

SentinelOne shares are trading lower. Barclays lowered its price target on the stock from $30 to $28.

SOUN

SoundHound AI shares are trading higher after the company announced it launched its voice AI wondering system at 130 Torchy's Tacos locations.

RBC Capital analyst Nik Modi reiterates The Campbell`s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Sector Perform and maintains $51 price target.

News

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Sector Perform on The Campbell's, Maintains $51 Price Target

Wells Fargo analyst Andrew Nowinski maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Equal-Weight and raises the price target from $80 to $95.

OKTA

Wells Fargo Maintains Equal-Weight on Okta, Raises Price Target to $95

UBS analyst Jay Sole maintains American Eagle Outfitters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) with a Buy and lowers the price target from $34 to $32.

UBS Maintains Buy on American Eagle Outfitters, Lowers Price Target to $32

Trading Ideas

LNKS

Linkers Industries Shares Resume Trade

Build-A-Bear Workshop shares are trading higher after the company reported a year-over-year increase in Q3 revenue results.

RBC Capital analyst Tom Narayan reiterates Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) with a Sector Perform and maintains $11 price target.

MBLY

RBC Capital Reiterates Sector Perform on Mobileye Global, Maintains $11 Price Target

UBS analyst Jay Sole maintains Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) with a Neutral and lowers the price target from $26 to $22.

UBS Maintains Neutral on Foot Locker, Lowers Price Target to $22

BLDP

Ballard Power Systems shares are trading higher after the company announced it signed a long-term supply agreement with Canadian Pacific Kansas City to initially provide 98 fuel cell engines for use in the North American freigth rail market.

On Thursday, Protara Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) stock traded higher after the company revealed results from its ongoing Phase 2 open-label <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42335401/protara-announces-positive-results-from-the-ongoing-phase-2-advanced-2-trial-of-tara-002-in-patien" rel="noreferrer noopener">ADVANCED-2 trial</a>.
The trial is assessing intravesical TARA-002, the company&#8217;s investigational cell-based therapy, in high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) patients with carcinoma in situ or CIS (± Ta/T1) who are Bacillus Calmette-Guérin (BCG)-Unresponsive or BCG-Naïve.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38114236/protara-therapeutics-shares-interim-data-from-bladder-cancer-study-raises-45m-via-equity" rel="noreferrer noopener">Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity</a>
The complete response (CR) rate across BCG exposures was 72% (13/18) at six months and 70% (14/20) at any time, with 100% (9/9) of patients maintaining a CR from three to six months.
In addition, two of three patients maintained a CR at nine months.
The results will be featured at the 25th Annual Meeting of the Society of Urologic Oncology.
The dataset includes 20 patients who were evaluable at three months, 18 at six months, and three at nine months, with a data cutoff of November 19.
In the pivotal cohort of the ADVANCED-2 trial in BCG-Unresponsive patients, the CR rate was 100% (4/4) at six months and 80% (4/5) at any time.
In the proof-of-concept cohort of BCG-Naïve patients, the CR rate was 64% (9/14) at six months and 67% (10/15) at any time.
TARA-002 demonstrated a favorable safety and tolerability profile with no Grade 2 or greater treatment-related adverse events (TRAEs) and no patients discontinued due to adverse events.
The company looks forward to reporting initial data from 12-month evaluable patients in mid-2025.
Price Action: At last check Thursday, TARA stock was up 119% at $7.73.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42340154/science-applications-q3-earnings-beats-estimates-launches-12-billion-share-buyback-outlook" target="_blank" rel="noreferrer noopener">Science Applications Approves $1.2 Billion Stock Buyback, Raises Annual Outlook After Q3 Beat</a></li>
</ul>
Photo by Aunt Spray via Shutterstock

Biotech

Health Care

Movers

TARA

Why Is Protara Therapeutics Stock Skyrocketing Over 100% On Thursday?

UBS analyst Dennis Geiger maintains Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) with a Neutral and raises the price target from $42 to $60.

CBRL

UBS Maintains Neutral on Cracker Barrel Old, Raises Price Target to $60

JMIA

Jumia Technologies shares are trading higher after the company announced a year-over-year increase in orders and gross merchant value.

RBC Capital analyst Jonathan Atkin reiterates GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) with a Outperform and maintains $26 price target.

RBC Capital Reiterates Outperform on GDS Holdings, Maintains $26 Price Target

Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) (FSE: 7301) explores integrating Bitcoin as an accepted payment method across its business platforms, the company announced on Wednesday.
The move aligns with the Flora&#8217;s commitment to innovation and meeting the evolving preferences of its global customer base.
The news that Flora intends to streamline cannabis payments follows a decision to renew its sales orders for the Czech Republic and Slovakia through <a href="https://www.benzinga.com/24/11/42218785/flora-growth-extends-500k-partnership-in-czech-republic-slovakia">Just Brands UK's customer Mirfa s.r.o</a>. and its third quarter financial results that revealed a 28% year-over-year <a href="https://www.benzinga.com/news/earnings/24/11/42009295/flora-growth-quarterly-revenue-falls-28-yoy-encouraged-by-president-elect-trump-and-the-potential-of-cannabis-reform">drop in revenue to $12.5 million.</a>
The company said that it is preparing the technological and operational frameworks needed to handle Bitcoin transactions securely and to hold Bitcoin as currency.
&#8220;Integrating Bitcoin is not just about staying ahead of the curve; it&#8217;s about giving our customers and partners more choice in how they transact with us,&#8221; CEO Clifford Starke said. &#8220;We see this as an opportunity to embrace innovation, attract new customers, and diversify our financial options in a way that aligns with Flora&#8217;s long-term vision for growth and accessibility.&#8221;
Flora aims to appeal to regions where cryptocurrency is widely used, viewing Bitcoin acceptance as a complementary addition to its existing payment systems.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/09/33254263/cannabis-goes-crypto-how-blockchain-might-save-a-100-billion-industry">Cannabis Goes Crypto: How Blockchain Might Save A $100 Billion Industry</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
The number of businesses using blockchain-powered cryptocurrencies specific to the cannabis industry, allowing for cashless transactions, has been growing for years.
In 2022, BankLine and B4U Financial partnered to incorporate B4U's payment solution into the cannabis industry. The collaboration aimed to integrate a global, proprietary digital currency payment system into the point of sale (POS) systems used by licensed cannabis businesses across the U.S.
The B4U payment network integrates with POS systems via API or as a standalone solution, working on any internet-enabled device. It allows Bitcoin payments for in-store, online, curbside, and home <a href="https://www.benzinga.com/markets/cannabis/22/08/28689914/cannabis-crypto-more-payment-solutions-for-marijuana-purchases">delivery transactions</a>.
Meanwhile, Bitcoin&#8217;s price has surged past the long-awaited $100,000 mark on Wednesday, for the first time in history, as <a href="https://www.cnbc.com/2024/12/05/bitcoin-tops-100000-as-monster-2024-rally-reaches-new-heights.html">reported</a> by CNBC.
Flora Growth&#8217;s shares traded 0.0063% higher at $1.5901 per share at the time of writing on Thursday morning. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41341406/anthony-scaramucci-talks-cannabis-vs-crypto-why-hes-not-a-huge-bull-although-the-bloom-is-off-th">Anthony Scaramucci Talks Cannabis Vs Crypto: Why He&#8217;s &#8216;Not a Huge Bull&#8217;—&#8217;The Bloom Is Off The Rose&#8217; For Stocks</a></li>
</ul>

Cannabis

Retail Sales

FLGC

Cannabis Co. Flora Growth Wants To Allow Customers To Pay With Bitcoin As It Shatters $100K Mark

Linkers Industries Shares Halted On Circuit Breaker To The Downside

Barclays analyst Julian Mitchell upgrades Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) from Equal-Weight to Overweight and raises the price target from $21 to $25.

Upgrades

GTES

Barclays Upgrades Gates Industrial Corp to Overweight, Raises Price Target to $25

HII (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HII#NYSE">HII</a>) was awarded a $6.7 billion contract to provide electronic warfare engineering and technical services support for the U.S. Air Force. The indefinite delivery/indefinite quantity contract is the largest ever awarded to HII's Mission Technologies division.

Contracts

HII Awarded $6.7B Contract To Support U.S. Air Force's Electronic Warfare Mission

Lands' End shares are trading lower after the company cut its FY24 net revenue guidance below estimates.

Gator Capital Management Q2 2024 Investor Letter

Greenlight Capital Q2 2024 Letter

Tracking David Einhorn's Greenlight Capital Portfolio - Q2 2024 Update

Harris Associates U.S. Concentrated Strategy Q2 2024 Commentary

BlackRock Equity Dividend Fund Q2 2024 Commentary

Middle Coast Investing Q3 2024 Investor Letter: Transitions And Timing

First Citizens BancShares, Inc. (FCNCA) Q3 2024 Earnings Call Transcript

Gator Capital Management Q3 2024 Investor Letter

BlackRock Equity Dividend V.I. Fund Q3 2024 Commentary

BlackRock Basic Value V.I. Fund Q3 2024 Commentary

AAPL

ACLS

ALIT

AMZN

APOG

ATKR

ATRO

ATROB

AVGO

BABA

BABAF

BACRP

BANC

BCLYF

BHFAL

BHFAM

BHFAN

BHFAO

BHFAP

BKNG

BOOM

BPAQF

BZZUF

BZZUY

CEIX

CMCSA

COLB

CPRI

CUBB

CUBI

DALN

FCNCB

FCNCP

GAERF

GLRE

GOGO

GOOG

GOOGL

GPOR

GRBK

HIFS

HOOD

HOUS

KRUS

KVUE

LBTYA

LBTYB

LBTYK

LIVN

LULU

NPWR

NVDA

OMAB

ONEXF

PAYC

PENN

PTLO

PTON

PYPL

ROIV

RYDAF

SCHW

SDRL

SHEL

SLMBP

SLVYY

SSNC

SSNLF

SVYSF

TCKRF

TECK

UMBF

VMEO

VNORP

VTRS

WFCNP

WFRD

WFTUF

Bank of America

Banco Bradesco Sa American Depositary Shares

Bank Bradesco

Banco Bradesco Sa American Depositary Shares (each representing one Common Share)

Banco Bilbao Vizcaya Argentaria S.A. Common Stock

BBVA

Barclays

Banco Santander Brasil SA American Depositary Shares, each representing one unit

Banco Santander

Citigroup

First Citizens BancShares, Inc. - Class A Common Stock

Fifth Third Bancorp

HDFC Bank

HSBC Holdings

ICICI Bank

ING Groep

Itau Unibanco Banco Holding SA American Depositary Shares (Each repstg 500 Preferred shares)

Itau Unibanco Holding

JPMorgan Chase

KB Financial Group

Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group

Mizuho Financial Group, Inc. Sponosred ADR (Japan)

Mizuho Financial Gr

Mitsubishi UFJ Financial Group, Inc. Common Stock

Mitsubishi UFJ Finl Gr

Nu Holdings

NatWest Group plc American Depositary Shares, (each representing two (2) Ordinary Shares)

NatWest Group

PNC Financial Services Group, Inc. (The) Common Stock

PNC Finl Servs Gr

Banco Santander, S.A. Sponsored ADR (Spain)

Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan)

Sumitomo Mitsui Finl Gr

U.S. Bancorp

Wells Fargo

Comments

First Citizens BancShares

First Citizens BancShares (FCNCO) Forecast

First Citizens BancShares (NASDAQ:FCNCO) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga